We are live on ! Find out more
AEMD icon

Aethlon Medical
AEMD

24 hedge funds and large institutions have $1.15M invested in Aethlon Medical in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

20% more funds holding

Funds holding: 20 → 24 (+4)

5% more capital invested

Capital invested by funds: $1.09M → $1.15M (+$57.8K)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
24
Holders Change
+4
Holders Change %
+20%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
6
Reduced
–
Closed
3
Calls
$80K
Puts
–
Net Calls
+$80K
Net Calls Change
+$80K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$601K
2
Citadel Advisors
Citadel Advisors
Florida
+$134K
3
Renaissance Technologies
Renaissance Technologies
New York
+$69.2K
4
N
Natixis
France
+$64.9K
5
Two Sigma Investments
Two Sigma Investments
New York
+$60.6K

Top Sellers

Rank Fund Capital Flow
1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$27K
2
TDC
Thompson Davis & Co
Virginia
-$11K
3
Citigroup
Citigroup
New York
-$8K

AEMD Hedge Fund Activity: Q3 2022 in Review

24 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q3 2022, worth a combined $1.15M — up 5.3% from $1.09M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new AEMD positions and 3 closed out — a net gain of 6 holders — while 6 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, adding an estimated $601K. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $27K sold.

  • 24 institutional investors held Aethlon Medical (AEMD) as of Q3 2022, up from 20 in Q2 2022.
  • Funds reported $1.15M of Aethlon Medical stock for Q3 2022, up 5.3% quarter-over-quarter.
  • 9 funds opened new Aethlon Medical positions in Q3 2022 and 3 closed out, a net change of +6 holders.
  • The largest Aethlon Medical buyer in Q3 2022 was Vanguard Group, an estimated $601K added.
  • The largest Aethlon Medical seller in Q3 2022 was Dimensional Fund Advisors, an estimated $27K sold.

Based on aggregated 13F filings for Q3 2022.